Desensitization of islet cells to bombesin involves both receptor down-modulation and inhibition of receptor function.
The neuropeptide bombesin has a powerful but transient stimulatory effect on insulin secretion in the pancreatic islet cell line HIT-T15. We have previously shown that pretreatment of HIT-T15 cells with a saturating concentration of bombesin (100 nM) for 1.5-2 hr abolishes their secretory response to a second challenge with peptide and decreases [125I-Tyr4]bombesin binding by over 90%. In this study we examined the mechanisms involved in desensitization to bombesin. To determine whether receptor modulation was responsible, we compared the effect of bombesin pretreatment on [125I-Tyr4]bombesin binding and on the ability of bombesin to stimulate insulin release. Both effects occurred very rapidly and were maximal by 10 min. Although pretreatment of cells for 90 min with a subsaturating concentration of bombesin did not affect either the ED50 for bombesin-stimulated secretion or the apparent Kd for bombesin binding, it decreased both the maximum secretory response to a subsequent challenge with the peptide and bombesin receptor number. However, the extent of desensitization was greater than the extent of receptor down-regulation at all times examined during pretreatment and recovery. Furthermore, bombesin was 3 times more potent at inducing desensitization (ED50 = 0.35 +/- 0.08 nM) than down-regulation (ED50 = 1.1 +/- 0.4 nM). These results suggest that desensitization was not due solely to a reduction in receptor number. Because bombesin stimulates diacylglycerol production in HIT-T15 cells, we used the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) to determine whether protein kinase C also played a role in desensitization to the peptide. Pretreatment of cells with TPA did not affect either [125I-Tyr4]bombesin binding or the dose dependence for bombesin-stimulated hormone release. However, TPA pretreatment did decrease the maximum secretory response to bombesin by 40% and caused a 50% reduction in bombesin-induced accumulation of inositol triphosphates and elevation of intracellular free calcium. Conversely, bombesin pretreatment reduced the secretory response to TPA by 40%. These studies indicate that the mechanism for desensitization to bombesin is a complex process that involves down-regulation of the bombesin receptor, inhibition of intracellular second messenger production, and reduction of protein kinase C-stimulated secretion.
Swope
S L
SL
Department of Pharmacology, Harvard Medical School, Boston, Massachusetts.
Schonbrunn
A
A
D000818:Animals; D001839:Bombesin / Q000378:metabolism / Q000494:pharmacology*; D002460:Cell Line; D015536:Down-Regulation / Q000187:drug effects*; D007295:Inositol Phosphates / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D007700:Kinetics; D011188:Potassium / Q000494:pharmacology; D018004:Receptors, Bombesin; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000502:physiology*; D015290:Second Messenger Systems; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D007295:Inositol Phosphates; D007328:Insulin; D018004:Receptors, Bombesin; D017981:Receptors, Neurotransmitter; D013755:Tetradecanoylphorbol Acetate; D001839:Bombesin; D011188:Potassium